Mannosylated Mucin-Type Immunoglobulin Fusion Proteins Enhance Antigen-Specific Antibody and T Lymphocyte Responses

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ahlén, Gustaf ^a   Strindelius, Lena ^a   Johansson, Tomas ^a   Nilsson, Anki ^a   Chatzissavidou, Nathalie ^a   Sjöblom, Magnus ^b   Rova, Ulrika ^b   Holgersson, Jan ^c  

^a Recopharma AB   (Sweden)

^b LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MANNOSE OLIGOSACCHARIDE; MANNOSE RECEPTOR; OVALBUMIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; PICHIA PASTORIS; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MANNOSE; MICE; MICE, INBRED C57BL; MUCINS; OVALBUMIN; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 84867409374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046959     Document Type: Article

References (63)

1. Apostolopoulos V, Pietersz GA, McKenzie IF, (1996) Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine 14: 930-938.
2. Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, et al. (1997) The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 27: 2417-2425.
3. Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, et al. (1997) Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 27: 2426-2435.
4. Keler T, Ramakrishna V, Fanger MW, (2004) Mannose receptor-targeted vaccines. Expert Opin Biol Ther 4: 1953-1962.
5. Apostolopoulos V, McKenzie IF, (2001) Role of the mannose receptor in the immune response. Curr Mol Med 1: 469-474.
6. Gordon S, (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111: 927-930.
7. Stahl PD, Ezekowitz RA, (1998) The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10: 50-55.
8. Geijtenbeek TB, Engering A, Van Kooyk Y, (2002) DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. J Leukoc Biol 71: 921-931.
9. Stahl PD, (1992) The mannose receptor and other macrophage lectins. Curr Opin Immunol 4: 49-52.
10. Taylor ME, (2001) Structure and function of the macrophage mannose receptor. Results Probl Cell Differ 33: 105-121.
11. Sallusto F, Cella M, Danieli C, Lanzavecchia A, (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389-400.
12. Uccini S, Sirianni MC, Vincenzi L, Topino S, Stoppacciaro A, et al. (1997) Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol 150: 929-938.
13. Apostolopoulos V, Pietersz GA, Gordon S, Martinez-Pomares L, McKenzie IF, (2000) Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur J Immunol 30: 1714-1723.
14. Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF, (1995) Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci U S A 92: 10128-10132.
15. Davis WC, Konzek RL, Haas K, Estes DM, Hamilton MJ, et al. (2002) Use of the mannan receptor to selectively target vaccine antigens for processing and antigen presentation through the MHC class I and class II pathways. Ann N Y Acad Sci 969: 119-125.
16. Luong M, Lam JS, Chen JM, Levitz SM, (2007) Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine 25: 4340-4344.
17. He LZ, Crocker A, Lee J, Mendoza-Ramirez J, Wang XT, et al. (2007) Antigenic targeting of the human mannose receptor induces tumor immunity. J Immunol 178: 6259-6267.
18. Lam JS, Mansour MK, Specht CA, Levitz SM, (2005) A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 175: 7496-7503.
19. Levitz SM, Specht CA, (2006) The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res 6: 513-524.
20. Burgdorf S, Lukacs-Kornek V, Kurts C, (2006) The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol 176: 6770-6776.
21. Kiessling LL, Pohl NL, (1996) Strength in numbers: non-natural polyvalent carbohydrate derivatives. Chem Biol 3: 71-77.
22. Lee YC, Lee RT, (1995) Carbohydrate-protein interactions: basis of glycobiology. Acc Chem Res 28: 321-327.
23. Roy R, (1996) Syntheses and some applications of chemically defined multivalent glycoconjugates. Curr Opin Struct Biol 6: 692-702.
24. Dam TK, Brewer CF, (2002) Thermodynamic studies of lectin-carbohydrate interactions by isothermal titration calorimetry. Chem Rev 102: 387-429.
25. Mammen M, Choi S, Whitesides G, (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37: 2754-2794.
26. Lee RT, Lee YC, (2000) Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconj J 17: 543-551.
27. Maaheimo H, Renkonen R, Turunen JP, Penttila L, Renkonen O, (1995) Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin. Eur J Biochem 234: 616-625.
28. Imberty A, Mikros E, Koca J, Mollicone R, Oriol R, et al. (1995) Computer simulation of histo-blood group oligosaccharides: energy maps of all constituting disaccharides and potential energy surfaces of 14 ABH and Lewis carbohydrate antigens. Glycoconj J 12: 331-349.
29. Bovin NV, (1998) Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj J 15: 431-446.
30. Gustafsson A, Holgersson J, (2006) A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions. Expert Opin Drug Discov 1: 161-178.
31. Gustafsson A, Sjöblom M, Strindelius L, Johansson T, Fleckenstein T, et al. (2011) Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system. Glycobiology 21 (8) (): 1071-86.
32. Irache JM, Salman HH, Gamazo C, Espuelas S, (2008) Mannose-targeted systems for delivery of therapeutics. Expert Opin Drug Deliv 5: 703-724.
33. Morein B, Hu KF, Abusugra I, (2004) Current status and potential application of ISCOMs in veterinary medicine. Adv Drug Deliv Rev 56: 1367-1382.
34. Sjolander A, Drane D, Maraskovsky E, Scheerlinck JP, Suhrbier A, et al. (2001) Immune responses to ISCOM formulations in animal and primate models. Vaccine 19: 2661-2665.
35. Sun HX, Xie Y, Ye YP, (2009) ISCOMs and ISCOMATRIX. Vaccine 27: 4388-4401.
36. Villacres MC, Behboudi S, Nikkila T, Lovgren-Bengtsson K, Morein B, (1998) Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction. Cell Immunol 185: 30-38.
37. Smith RE, Donachie AM, Grdic D, Lycke N, Mowat AM, (1999) Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses. J Immunol 162: 5536-5546.
38. Windon RG, Chaplin PJ, Beezum L, Coulter A, Cahill R, et al. (2000) Induction of lymphocyte recruitment in the absence of a detectable immune response. Vaccine 19: 572-578.
39. Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, et al. (2011) ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J Immunol 187: 55-63.
40. Espuelas S, Thumann C, Heurtault B, Schuber F, Frisch B, (2008) Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Bioconjug Chem 19: 2385-2393.
41. White K, Rades T, Kearns P, Toth I, Hook S, (2006) Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res 23: 1473-1481.
42. Sheng K-C, Kalkanidis M, Pouniotis DS, Esparon S, Tang CK, et al. (2008) Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur J Immunol 38: 424-436.
43. Sheng KC, Kalkanidis M, Pouniotis DS, Wright MD, Pietersz GA, et al. (2008) The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells. J Immunol 181: 2455-2464.
44. Engering AJ, Cella M, Fluitsma DM, Hoefsmit EC, Lanzavecchia A, et al. (1997) Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 417: 183-187.
45. Engering A, Geijtenbeek TBH, van Vliet SJ, Wijers M, van Liempt E, et al. (2002) The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. Journal of Immunology 168: 2118-2126.
46. Blander JM, Medzhitov R, (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
47. Blander JM, Medzhitov R, (2006) On regulation of phagosome maturation and antigen presentation. Nature Immunology 7: 1029-1035.
48. Tada H, Nemoto E, Shimauchi H, Watanabe T, Mikami T, et al. (2002) Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 46: 503-512.
49. Netea MG, Gow NAR, Munro CA, Bates S, Collins C, et al. (2006) Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 116: 1642-1650.
50. Netea MG, Gow NAR, Joosten LAB, Verschueren I, Van der Meer JWM, et al. (2010) Variable recognition of Candida albicans strains by TLR4 and lectin receptors. Med Mycol 48: 897-903.
51. Brincks EL, Katewa A, Kucaba TA, Griffith TS, Legge KL, (2008) CD8 T cells utilize TRAIL to control influenza virus infection. Journal of Immunology 181: 4918-4925.
52. Epstein SL, Lo CY, Misplon JA, Bennink JR, (1998) Mechanism of protective immunity against influenza virus infection in mice without antibodies. Journal of Immunology 160: 322-327.
53. Woolard SN, Kumaraguru U, (2010) Viral Vaccines and CTL Response. Journal of Biomedicine and Biotechnology.
54. Haicheur N, Bismuth E, Bosset S, Adotevi O, Warnier G, et al. (2000) The B subunit of shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. Journal of Immunology 165: 3301-3308.
55. Belizaire R, Unanue ER, (2009) Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proceedings of the National Academy of Sciences of the United States of America 106: 17463-17468.
56. Bretthauer RK, Castellino FJ, (1999) Glycosylation of Pichia pastoris-derived proteins. Biotechn Appl Biochem 30: 193-200.
57. Trimble RB, Lubowski C, Hauer CR, Stack R, McNaughton L, et al. (2004) Characterization of N- and O-linked glycosylation of recombinant human bile salt-stimulated lipase secreted by Pichia pastoris. Glycobiology 14: 265-274.
58. Apostolopoulos V, Barnes N, Pietersz GA, McKenzie IFC, (2000) Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine 18: 3174-3184.
59. Brown GD, Gordon S, (2001) Immune recognition- A new receptor for beta-glucans. Nature 413: 36-37.
60. Dennehy KM, Brown GD, (2007) The role of the beta-glucan receptor Dectin-1 in control of fungal infection. Journal of Leukocyte Biology 82: 253-258.
61. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, et al. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nature Immunology 8: 630-638.
62. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology 6: 1123-1132.
63. Park H, Li ZX, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 6: 1133-1141.